Key result
Intra-arterial reperfusion boosts recanalization over IV thrombolysis in stroke without improving functional outcomes.
Answers are grounded in this paper and cite their sources.
PURPOSE OF REVIEW: Modern reperfusion therapy in acute ischemic stroke therapy is based on an 'as fast as possible' recanalization approach to obtain favorable clinical outcomes. However, arterial recanalization may be achieved without favorable clinical outcome, raising the question of the target population to be treated. We outline key issues that underline acute revascularization therapies. RECENT FINDINGS: Intravenous (i.v.) thrombolysis remains the gold standard with the benefit of speed but lower recanalization rates of large artery occlusions as compared with intra-arterial routes. Conversely, intra-arterial therapies report higher recanalization rates, but are hampered by procedural delays and risks. Higher rates of recanalization in intra-arterial studies using clot-removal devices have not translated into improved patient functional outcome as compared with i.v. thrombolysis trials. Combined i.v.-intra-arterial therapy hold great promise with both the advantages of i.v. and intra-arterial routes. SUMMARY: Endovascular therapy is potentially superior to i.v. tissue-type plasminogen activator with the development of new devices, which are now available, but none has been evaluated vs. i.v. thrombolysis. Future developments may include combined strategies or a 'pure' mechanical approach. The critical issue is time-to-reperfusion based on a brain imaging showing salvageable brain tissue with a reduced risk of adverse events associated with reperfusion. Current brain imaging techniques are probably not good enough to discriminate salvageable brain, and parenchymal lesion that may suffer from reperfusion injury.
No takes yet. Share an insight, caveat, or question.
Mazighi et al. (2010) conducted a review in Acute ischemic stroke. Endovascular / intra-arterial reperfusion therapy vs. Intravenous thrombolysis (tissue-type plasminogen activator) was evaluated on Arterial recanalization and functional clinical outcome. Intra-arterial reperfusion therapies achieve higher recanalization rates in acute ischemic stroke than intravenous thrombolysis, without yet demonstrating improved functional outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: